ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 139 filers reported holding ANAPTYSBIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,744,783 | -11.7% | 431,224 | 0.0% | 0.73% | +3.4% |
| Q2 2023 | $8,771,096 | -6.5% | 431,224 | 0.0% | 0.71% | -8.8% |
| Q1 2023 | $9,383,434 | -29.8% | 431,224 | +0.0% | 0.78% | -31.8% |
| Q4 2022 | $13,357,434 | +21.5% | 431,024 | 0.0% | 1.14% | +31.1% |
| Q3 2022 | $10,995,000 | +25.7% | 431,024 | 0.0% | 0.87% | +13.9% |
| Q2 2022 | $8,750,000 | -17.9% | 431,024 | 0.0% | 0.76% | -7.4% |
| Q1 2022 | $10,664,000 | -29.7% | 431,024 | -1.3% | 0.82% | -15.1% |
| Q4 2021 | $15,172,000 | +28.1% | 436,592 | 0.0% | 0.97% | +35.7% |
| Q3 2021 | $11,840,000 | +4.6% | 436,592 | 0.0% | 0.72% | +14.6% |
| Q2 2021 | $11,321,000 | +20.3% | 436,592 | 0.0% | 0.62% | +16.4% |
| Q1 2021 | $9,409,000 | +5.1% | 436,592 | +4.9% | 0.54% | +14.3% |
| Q4 2020 | $8,950,000 | +64.6% | 416,292 | +12.9% | 0.47% | +56.9% |
| Q3 2020 | $5,439,000 | – | 368,722 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |